← Leaderboards
John L. Magnani
Glycotech Corporation
$450,284
Attributed
$450,284
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $190.7K · FY2009–10$200K$150K$100K$50K$0
'09
'10
Funding mix
By agency
NIH$450,284 · 2
By mechanism
R21$350,284 · 1
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cell Adhesion”
- Timothy A Springer · Boston Children'S Hospital$37,409,994
- Kristiina Vuori · Burnham Institute For Medical Research$30,579,982
- John S Condeelis · Yeshiva University$22,815,752
- Kathleen Janee Green · Northwestern University$21,491,141
- Ulrich H Von Andrian · Harvard Medical School$20,977,205
- Mark Howard Ginsberg · University Of California, San Diego$19,912,725
Research focus
Cell AdhesionDiabetic NephropathyCapillaryDiabetes MellitusAdme StudyBaseAlbuminsAbsorptionAdhesionsDesignBlood CapillariesBlood CellsBlood FlowBlood VesselsComplications Of Diabetes MellitusCarbohydratesBiological AvailabilityCardiovascular SystemDiabetic MouseCell Adhesion MoleculesBloodCellsChronicDiabetic Retinopathy
Grant awards (3)
Selectin inhibitor therapeutics for blood flow related complications of diabetes$159,562
R21 · FY2010 · HL · contact PI
Selectin inhibitor therapeutics for blood flow related complications of diabetes$190,722
R21 · FY2009 · HL · contact PI
FUCOSYLTRANSFERASE INHIBITORS WITH THERAPEUTIC POTENTIAL$100,000
R43 · FY2001 · AI